NMI 8739 is primarily used in research and development within the pharmaceutical industry, particularly in the study of neurodegenerative diseases. It has shown potential as a therapeutic agent for conditions like Alzheimer's and Parkinson's disease due to its ability to modulate specific biological pathways involved in neurodegeneration. Researchers are exploring its efficacy in reducing neuroinflammation and preventing neuronal cell death, which are critical factors in the progression of these diseases. Additionally, NMI 8739 is being investigated for its role in enhancing cognitive function and memory retention in preclinical models. Its application extends to the development of novel drug candidates aimed at addressing unmet medical needs in the field of neurology.